CASR and breast carcinoma: Elevated serum calcium has been coupled with poorer prognosis in breast cancer even without bone metastases, therefore polymorphisms previously predicted to decrease the sensitivity of the CaSR (A986S and Q1011E) are also in the focus in some oncological investigations concerning breast cancer.